Buteon Institutional Intelligence

ARK Invest holdings

Investment adviser. Reported Form 13F holdings as of Jun 30, 2026—with the evidence and the limits kept in view.

Position date · Q2 2026
Jun 30, 2026
When the portfolio was measured.
Disclosure date
Aug 14, 2026
When this filing became public.
Sources reviewed
Sep 25, 2026
Next expected season: November 2026.

Reported positions may have changed since Jun 30, 2026. Coverage is curated, not universal or real-time.

In 15 seconds

What ARK Invest reported

What was reported
191 source rows. 1 carry a PUT/CALL designation and are shown separately.
The clearest takeaway
Tesla Inc is the largest individual row without a PUT/CALL designation, at $1,160,772,073. Inspect the table.
Why it may matter
The filing documents disclosed exposure. It gives you a dated starting point for researching the named companies.
What it does not prove
Positions held today, trade dates, conviction, or a complete view of the manager’s assets and risks.

Legal filer: ARK Investment Management LLC · CIK 1697748 · Form 13F file 028-17768

Buteon’s filing assessment
What stands out
191 filed rows provide a dated record of disclosed exposure.
How readable is it?
Options and other-manager rows limit a directional reading. Gross reported value is not a net position.
Is it fresh?
Latest complete reporting period, but measured on Jun 30, 2026. Useful as a disclosure record; stale as a claim about positions held today.
The reported record

Largest rows without a PUT/CALL designation

Ranked by reported value; up to 20 individual source rows. Repeated securities stay separate because manager relationships can overlap. SH means shares; PRN means principal amount. This section can include instruments other than common stock.

Reported rows · position date Jun 30, 2026
Reported securityShares / principalReported valueQ/Q sharesEvidence
Tesla IncCommon Stock · No PUT/CALL
CUSIP 88160R101
2,759,800 SHReported share quantity$1,160,772,073As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 35
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 2,720,468, shared 39,332, none 0
0001104659-26-096910
Advanced Micro Devices IncCommon Stock · No PUT/CALL
CUSIP 007903107
1,416,443 SHReported share quantity$822,826,048As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 106
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 1,360,375, shared 13,804, none 42,264
0001104659-26-096910
Space Exploration Technologies CorpCommon Stock · No PUT/CALL
CUSIP 84615Q103
4,478,013 SHReported share quantity$765,113,281As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 184
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 4,434,414, shared 43,599, none 0
0001104659-26-096910
Tempus AI IncCommon Stock · No PUT/CALL
CUSIP 88023B103
10,022,634 SHReported share quantity$580,611,200As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 123
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 9,379,994, shared 183,555, none 459,085
0001104659-26-096910
Robinhood Markets IncCommon Stock · No PUT/CALL
CUSIP 770700102
5,236,031 SHReported share quantity$525,069,168As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 83
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 4,711,595, shared 95,922, none 428,514
0001104659-26-096910
CRISPR Therapeutics AGCommon Stock · No PUT/CALL
CUSIP H17182108
9,460,939 SHReported share quantity$515,999,631As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 43
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 8,755,408, shared 146,873, none 558,658
0001104659-26-096910
Shopify IncCommon Stock · No PUT/CALL
CUSIP 82509L107
4,155,925 SHReported share quantity$474,523,465As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 32
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 3,921,119, shared 60,244, none 174,562
0001104659-26-096910
Twist Bioscience CorpCommon Stock · No PUT/CALL
CUSIP 90184D100
4,549,803 SHReported share quantity$468,083,756As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 40
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 4,254,988, shared 58,669, none 236,146
0001104659-26-096910
10X Genomics IncCommon Stock · No PUT/CALL
CUSIP 88025U109
10,003,057 SHReported share quantity$383,517,223As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 62
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 9,343,839, shared 122,999, none 536,219
0001104659-26-096910
Amazon.com IncCommon Stock · No PUT/CALL
CUSIP 023135106
1,591,177 SHReported share quantity$379,241,133As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 5
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 1,529,492, shared 16,120, none 45,565
0001104659-26-096910
Palantir Technologies IncCommon Stock · No PUT/CALL
CUSIP 69608A108
3,212,286 SHReported share quantity$374,777,381As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 108
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 3,063,834, shared 37,037, none 111,415
0001104659-26-096910
Alphabet IncCommon Stock · No PUT/CALL
CUSIP 02079K107
1,043,334 SHReported share quantity$368,641,312As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 4
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 1,011,409, shared 8,525, none 23,400
0001104659-26-096910
Coinbase Global IncCommon Stock · No PUT/CALL
CUSIP 19260Q107
2,511,319 SHReported share quantity$367,129,713As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 78
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 2,332,910, shared 43,354, none 135,055
0001104659-26-096910
ROBLOX CorpCommon Stock · No PUT/CALL
CUSIP 771049103
6,465,890 SHReported share quantity$351,615,103As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 77
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 6,037,445, shared 99,509, none 328,936
0001104659-26-096910
Beam Therapeutics IncCommon Stock · No PUT/CALL
CUSIP 07373V105
10,234,862 SHReported share quantity$351,260,447As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 65
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 9,639,107, shared 151,313, none 444,442
0001104659-26-096910
Teradyne IncCommon Stock · No PUT/CALL
CUSIP 880770102
644,782 SHReported share quantity$311,971,420As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 34
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 633,091, shared 2,941, none 8,750
0001104659-26-096910
Intellia Therapeutics IncCommon Stock · No PUT/CALL
CUSIP 45826J105
16,875,684 SHReported share quantity$285,536,575As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 14
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 15,674,680, shared 278,640, none 922,364
0001104659-26-096910
Circle Internet Group IncCommon Stock · No PUT/CALL
CUSIP 172573107
4,558,162 SHReported share quantity$285,477,674As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 145
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 4,277,793, shared 77,612, none 202,757
0001104659-26-096910
NVIDIA CorpCommon Stock · No PUT/CALL
CUSIP 67066G104
1,381,247 SHReported share quantity$276,373,746As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 94
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 1,321,374, shared 13,066, none 46,807
0001104659-26-096910
CoreWeave IncCommon Stock · No PUT/CALL
CUSIP 21873S108
2,657,192 SHReported share quantity$264,496,911As of Jun 30, 2026Not comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 141
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 2,500,898, shared 39,455, none 116,839
0001104659-26-096910

Showing 20 of 190 non-option source rows. Read the complete information table.

Options, separately

Largest 1 of 1 held-option rows. Values refer to underlying securities, not option premiums. Short stock, written options, strike and expiry are absent; net direction cannot be reconstructed.

PUT/CALL-designated rows · never added to common shares
Reported securityShares / principalReported valueQ/Q sharesEvidence
ARK Innovation ETFETP · Call
CUSIP 00214Q104
8,900 SHReported share quantity$719,298Underlying security value, not option premiumNot comparableCorporate-action or row-identity review not completed; no trading direction inferred.Filed row 191
Row provenanceDiscretion: SOLE
Other manager: None listed
Voting: sole 8,900, shared 0, none 0
0001104659-26-096910
One filing lesson

A reported portfolio is a snapshot, not a trading diary.

Each row describes the end of a quarter. Changes in reportability, instrument terms, manager assignments and corporate actions can make an apparent change misleading.

Interpretation, not an investment recommendation.

What changed—and what needs review

The current and prior source tables reconcile, but corporate-action and manager-row review is not complete. We do not label increases, reductions, new positions or exits yet. “Not comparable” means the directional conclusion is withheld, not that nothing changed.

Composition of this filing

By number of filed rows

Denominator: 191 rows · same filing

Without PUT/CALL99.48%190 rows
Held calls0.52%1 rows
Held puts0.00%0 rows

Verified derivation from 0001104659-26-096910. Source rows, without cross-manager aggregation.

By gross reported value

Denominator: $15,402,788,184 · same filing

Without PUT/CALL100.00%$15,402,068,886
Held calls0.00%$719,298
Held puts0.00%$0

Verified derivation from 0001104659-26-096910. Source rows, without cross-manager aggregation.

Quarter archive

Authoritative filing · 13F-HR

Position date Jun 30, 2026 · filed Aug 14, 2026

Accepted timestamp (SEC): 2026-08-14T18:41:16.000Z

0001104659-26-096910

Cover page · Information table

191 source rows · $15,402,788,184 gross reported table value. Both reconcile to the cover; this is not assets under management.

Included managers and report type

13F HOLDINGS REPORT · File 028-17768

No included other managers listed.

Q1 2026 · positions as of Mar 31, 2026

Previous reporting period · 13F-HR

Position date Mar 31, 2026 · filed May 12, 2026

Accepted timestamp (SEC): 2026-05-12T17:32:25.000Z

0001104659-26-059240

Cover page · Information table

182 source rows · $12,859,485,476 gross reported table value. Both reconcile to the cover; this is not assets under management.

Included managers and report type

13F HOLDINGS REPORT · File 028-17768

No included other managers listed.

Prior-period rows are retained in the evidence pack. Compare only after corporate-action clearance.

No Form 13F-HR/A amendment was found for either quarter in EDGAR submissions reviewed through Sep 25, 2026. An amendment filed later could change these rows.

Companies in this record

Related portfolios

Institutions that reported the most of the same covered companies this quarter.

Filing Reality Check · eleven evidence questions
The instrument every dossier uses

The eleven questions, in the fixed order.

#QuestionAnswerEvidence class
1What was reported191 individual information-table rows. Options remain separate.Filed fact
2Who filed itARK Investment Management LLC, CIK 1697748, file 028-17768.Filed fact
3When it was trueJun 30, 2026Filed fact
4When it went publicAug 14, 2026Filed fact
5Filed factsQuantities, values, security classes, option sides, discretion, voting fields and included managers.Filed fact
6What we calculatedRow rankings and composition percentages against this filing’s own totals; only specifically cleared share comparisons.Verified derivation
7Instrument & rulesForm 13F is a delayed record of reportable securities. It omits short stock and written options.Interpretation
8How clear, and whyOptions and overlapping manager relationships prevent reconstruction of net direction.Interpretation
9What it can't showTrade dates, full assets under management, current positions, net exposure or conviction.Unresolved
10What would helpCorporate-action review, manager-relationship clearance and newer primary disclosures.Interpretation
11The filings behind itCurrent 0001104659-26-096910; prior 0001104659-26-059240. No Form 13F-HR/A amendment was found for either quarter in EDGAR submissions reviewed through Sep 25, 2026. An amendment filed later could change these rows.Filed fact
Methodology & corrections

The source stays beside the claim.

SEC Form 13F cover pages and information tables are the numerical authority. We reconcile every accepted table to its cover, retain each source row, and keep options separate. Reported values are whole US dollars. We do not add holdings across filers or estimate an ownership percentage.

A matching security identifier alone is not enough for a quarter comparison. Until amendments, corporate actions and manager relationships are cleared, the result is “not comparable.” A newly reported row need not be a new purchase, and a missing row need not prove a sale.

How to read Form 13F · SEC methodology and filing calendar · Report a correction

Data version 2026-q2.2026-09-25.4. Review cutoff 2026-09-25. Corrections require a primary source and a new reviewed data version.

Holdings are one piece of the picture

A filing answers what was reported. The next question is what matters.

Is it new or routine? Is it still fresh? What other public evidence supports it—and what happened after similar signals? Buteon is being built to connect those questions across filings, company events and market context.

Institutional filings are designed to become one evidence class in Buteon’s broader intelligence framework. This curated research surface shows what the filings establish today; it does not feed production company verdicts or provide automated institutional alerts.

Explore Buteon